摘要
载脂蛋白E4(apoE4),最常见的阿尔茨海默氏病(AD)的遗传危险因素,与神经元和血管损伤有关。最近的研究结果表明apoE4老鼠的视网膜有突触受损和功能障碍。我们目前研究apoE4对视网膜和脉络膜的脉管系统的影响及在这些影响中血管内皮生长因子可能产生的作用。apoE3和apoE4幼鼠的视网膜与脉络膜的血管没有组织学差异。相反,apoE4老鼠较apoE3老鼠因激光所致脉络膜损伤诱发更高水平的脉络膜新生血管性疾病(CNV)。apoE4老鼠更明显地表现出这些影响与炎症反应以及米勒细胞、星形细胞标记物、谷胱甘肽合成酶和胶质纤维酸性蛋白的激活有关。然而,apoE3和apoE4幼鼠中CNV同样会诱发类似的突触标记物突触素和突触后密度蛋白95抗体水平的短暂增加。apoE4老鼠的视网膜和脉络膜的血管内皮生长因子和载脂蛋白E水平较apoE3老鼠的含量低。相比之下, apoE4老鼠较apoE3老鼠因激光损伤所致血管内皮生长因子和载脂蛋白E水平上升更显著。总的来说,这些发现表明:在基础条件下,apoE4诱发的视网膜损伤可能与这些老鼠眼睛中降低的血管内皮生长因子水平有关。apoE4老鼠高发新生血管性疾病可能取决于炎症反映增加和受损后相关的血管内皮生长因子激增。
关键词: 阿尔茨海默氏病;载脂蛋白E4;脉络膜;新生血管性疾病;视网膜;突触;目标替代鼠;血管内皮生长因子。
Current Alzheimer Research
Title:VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina
Volume: 12 Issue: 4
Author(s): Ran Antes, Shiran Salomon-Zimri, Susanne C. Beck, Marina Garcia Garrido and Tami Livnat, Idit Maharshak, Tamar Kadar, Mathias Seeliger, Dov Weinberger and Daniel M. Michaelson
Affiliation:
关键词: 阿尔茨海默氏病;载脂蛋白E4;脉络膜;新生血管性疾病;视网膜;突触;目标替代鼠;血管内皮生长因子。
摘要: Apolipoprotein E4 (apoE4), the most prevalent genetic risk factor for Alzheimer's disease (AD), is associated with neuronal and vascular impairments. Recent findings suggest that retina of apoE4 mice have synaptic and functional impairments. We presently investigated the effects of apoE4 on retinal and choroidal vasculature and the possible role of VEGF in these effects. There were no histological differences between the retinal and choroidal vasculatures of naïve apoE3 and apoE4 mice. In contrast, laserdriven choroidal injury induced higher levels of choroidal neovascularization (CNV) in apoE4 than in apoE3 mice. These effects were associated with an inflammatory response and with activation of the Muller cells and asrocytic markers gluthatione synthetase and GFAP, all of which were more pronounced in the apoE4 mice. CNV also induced a transient increase in the levels of the synaptic markers synaptophysin and PSD95 which were however similar in the apoE4 and apoE3 naive mice. Retinal and choroidal VEGF and apoE levels were lower in naïve apoE4 than in corresponding apoE3 mice. In contrast, VEGF and apoE levels rose more pronouncedly following laser injury in the apoE4 than in apoE3 mice. Taken together, these findings suggest that the apoE4-induced retinal impairments, under basal conditions, may be related to reduced VEGF levels in the eyes of these mice. The hyper-neovascularization in the apoE4 mice might be driven by increased inflammation and the associated surge in VEGF following injury.
Export Options
About this article
Cite this article as:
Ran Antes, Shiran Salomon-Zimri, Susanne C. Beck, Marina Garcia Garrido and Tami Livnat, Idit Maharshak, Tamar Kadar, Mathias Seeliger, Dov Weinberger and Daniel M. Michaelson , VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina, Current Alzheimer Research 2015; 12 (4) . https://dx.doi.org/10.2174/1567205012666150325182504
DOI https://dx.doi.org/10.2174/1567205012666150325182504 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Erythropoietin and Oxidative Stress
Current Neurovascular Research Vitamin D and Vitamin D Receptor Activators in Treatment of Hypertension and Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets The Impact of Metabolic Disease Associated with Metabolic Syndrome on Human Pregnancy
Current Pharmaceutical Biotechnology Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters Role of Inflammatory Cells and Toll-Like Receptors in Atherosclerosis
Current Vascular Pharmacology Statins and Inflammation in Cardiovascular Disease
Current Pharmaceutical Design Integrins in Pulmonary Inflammatory Diseases
Current Pharmaceutical Design Non Enzymatic Glycated Proteins in the Blood and Cardiovascular Disease
Current Pharmaceutical Design S-Nitrosothiols as Nitric Oxide-Donors: Chemistry, Biology and Possible Future Therapeutic Applications
Current Medicinal Chemistry Systemic Hypertension in Patients with Aortic Stenosis: Clinical Implications and Principles of Pharmacological Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Oxidative Stress and Antioxidative Enzyme Activities in Chronic Kidney Disease and Different Types of Renal Replacement Therapy
Current Protein & Peptide Science Using Bioinformatics Techniques for Gene Identification in Drug Discovery and Development
Current Drug Metabolism Neuroimmune Activation in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Mechanisms of Biological Activity of Oleanolic Acid - A Source of Inspiration for A New Drugs Design
Mini-Reviews in Organic Chemistry Editorial [Hot Topic Biomarkers, Molecular Imaging, and Novel Therapies of Cancer]
Current Molecular Medicine Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Current Alzheimer Research Coronary Calcium Risk Score and Cardiovascular Risk
Current Vascular Pharmacology Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Therapy Of Cardiac Arrhythmias In Children: An Emerging Role Of Electroanatomical Mapping Systems
Current Vascular Pharmacology Tolerability of Amine Uptake Inhibitors in Urologic Diseases
Current Drug Safety